Is Bacillus Calmette-Guerin revaccination necessary for Japanese children?

Preventive Medicine

Volumn 35, Issue 1, 2002, Pages 70-77

  Rahman, Mahbubur ^a   Sekimoto, Miho ^a   Hira, Kenji ^a   Koyama, Hiroshi ^a   Imanaka, Yuichi ^a   Fukui, Tsuguya ^a  

^a KYOTO UNIVERSITY   (Japan)

Author keywords

Bacillus Calmette Guerin (BCG); Cost benefit analysis; Cost effectiveness analysis; Japan; Revaccination; Tuberculosis

Indexed keywords

BCG VACCINE;

ARTICLE; BCG VACCINATION; CONTROLLED STUDY; COST BENEFIT ANALYSIS; COST EFFECTIVENESS ANALYSIS; DRUG COST; DRUG EFFICACY; ECONOMIC EVALUATION; HEALTH CARE POLICY; HUMAN; IMMUNIZATION; INCIDENCE; JAPAN; MORTALITY; NORMAL HUMAN; PREVALENCE; PRIORITY JOURNAL; REVACCINATION; SCHOOL CHILD; TUBERCULOSIS;

EID: 0036310918     PISSN: 00917435     EISSN: None     Source Type: Journal    
DOI: 10.1006/pmed.2002.1043     Document Type: Article

References (29)

1. BCG: Bad news from India
2. BCG vaccination after the Madras study
3. BCG vaccination against tuberculosis and leprosy
4. Trial of BCG vaccines in south India for tuberculosis prevention
5. Efficacy of Bacillus Calmette-Guerin vaccination of newborns and infants in the prevention of tuberculosis: Meta-analysis of the published literatures
6. Theoretical and methodological aspects of BCG vaccine from the discovery of Calmette and Guerin to molecular biology: A review
7. Effectiveness of BCG vaccination
8. Case-control study of the efficacy of BCG immunization against pulmonary tuberculosis in young adults in Santiago, Chile
9. Randomized controlled trial of single BCG, repeated BCG, or combined BCG and killed Mycobacterium leprae vaccine for prevention of leprosy and tuberculosis in Malawi
10. The current situation and treatment of childhood tuberculosis
11. Does the efficacy of BCG decline with time since vaccination?
12. Economic evaluation of universal BCG vaccination among Japanese infants
13. The examination of tuberculosis contacts: The current situations and perspective in Japan
14. Six-month chemotherapy of pulmonary tuberculosis in children
15. The inverse association between tuberculin response and atopic disorder
16. Bacillus Calmette-Guerin revaccination questionable with low tuberculosis incidence
17. Global tuberculosis programme and global programme on vaccines: Statement on BCG revaccination for the prevention of tuberculosis
18. Enzyme replacement therapy for a patient with adenosine deaminase deficiency using polyethylene glycol-modified adenosine deaminase
19. A case of severe combined immunodeficiency accompanied with miliary BCG infectious disease
20. A case of disseminated BCG infection determined by genetic diagnosis
21. A case of chronic granulomatosis with disseminated BCG infection
22. Efficacy of various durations of isoniazid preventive therapy for tuberculosis: Five years of follow-up in the IUAT trial
23. Identification of an effective vaccine against tuberculosis
24. Characteristics of tuberculosis in Japan compared with those in other developed countries